Dietary monounsaturated fat in early life regulates IGFBP2: Implications for fat mass accretion and insulin sensitivity

Obesity

Volumn 19, Issue 12, 2011, Pages 2374-2381

  Sabin, Matthew A ^a,b,c   Yau, Steven W ^a   Russo, Vincenzo C ^a,b   Clarke, Iain J ^c   Dunshea, Frank R ^b   Chau, Jillian ^a   Cox, Maree ^b   Werther, George A ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE; ALPHA ACTIN; ALPHA ACTIN 1; FATTY ACID; FATTY ACID SYNTHASE; INSULIN; INSULIN RECEPTOR; MESSENGER RNA; MONOUNSATURATED FATTY ACID; MYOD PROTEIN; MYOGENIN; OLEIC ACID; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SATURATED FATTY ACID; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; STEAROYL COA DESATURASE 1; SUCROSE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3;

ABDOMINAL OBESITY; ACETYL COENZYME A CARBOXYLASE GENE; ALPHA ACTIN 1 GENE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY FAT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; DUAL ENERGY X RAY ABSORPTIOMETRY; EARLY LIFE DIETARY FAT; EXPERIMENTAL PIG; FAT INTAKE; FAT MASS; FATTY ACID BLOOD LEVEL; FATTY ACID SYNTHASE GENE; FOOD COMPOSITION; FOOD INTAKE; GENE; GENE EXPRESSION; IGFBP2 GENE; IGFBP3 GENE; IN VITRO STUDY; INSULIN LIKE GROWTH FACTOR 1 GENE; INSULIN LIKE GROWTH FACTOR 1 RECEPTOR GENE; INSULIN LIKE GROWTH FACTOR 2 GENE; INSULIN RECEPTOR GENE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LEAN MUSCLE MASS; LIPOGENESIS; MUSCLE MASS; MYOD GENE; MYOGENIN GENE; MYOTUBE; NONHUMAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA GENE; SKELETAL MUSCLE; STEAROYL COA DESATURASE 1 GENE; SUBCUTANEOUS FAT; TISSUE CULTURE; UCP2 GENE; UCP3 GENE; VISCERAL FAT WEIGHT; WEIGHT GAIN;

ANIMALS; BODY COMPOSITION; CELL LINE; DIET; DIETARY FATS; DIETARY SUCROSE; ENERGY INTAKE; FASTING; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, NONESTERIFIED; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INTRA-ABDOMINAL FAT; MICE; MUSCLE FIBERS, SKELETAL; OBESITY, ABDOMINAL; RANDOM ALLOCATION; RNA, MESSENGER; SWINE; WEIGHT GAIN;

ANIMALIA; SUIDAE;

EID: 81855185267     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.55     Document Type: Article

References (40)

1. Bell LM, Byrne S, Thompson A et al. Increasing body mass index z-score is continuously associated with complications of overweight in children, even in the healthy weight range. J Clin Endocrinol Metab 2007;92:517-522.
2. Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ; International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2006-2007. Type 2 diabetes mellitus in the child and adolescent. Pediatr Diabetes 2008;9:512-526.
3. Demmelmair H, Von Rosen J, Koletzko B. Long-term consequences of early nutrition. Early Hum Dev 2006;82:567-574.
4. Ong KK, Dunger DB. Birth weight, infant growth and insulin resistance. Eur J Endocrinol 2004;151 Suppl 3:U131-U139.
5. Coupé B, Amarger V, Grit I, Benani A, Parnet P. Nutritional programming affects hypothalamic organization and early response to leptin. Endocrinology 2010;151:702-713.
6. Ong K, Kratzsch J, Kiess W, Dunger D; ALSPAC Study Team. Circulating IGF-I levels in childhood are related to both current body composition and early postnatal growth rate. J Clin Endocrinol Metab 2002;87: 1041-1044.
7. Wheatcroft SB, Kearney MT. IGF-dependent and IGF-independent actions of IGF-binding protein-1 and-2: implications for metabolic homeostasis. Trends Endocrinol Metab 2009;20:153-162.
8. Chan SS, Schedlich LJ, Twigg SM, Baxter RC. Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3. Am J Physiol Endocrinol Metab 2009;296:E654-E663.
9. Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev 1999;15:314-322.
10. Heald AH, Kaushal K, Siddals KW et al. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome. Exp Clin Endocrinol Diabetes 2006;114:371-376.
11. Ballerini MG, Ropelato MG, Domené HM et al. Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis. J Pediatr Endocrinol Metab 2004;17:749-757.
12. Hession M, Rolland C, Kulkarni U, Wise A, Broom J. Systematic review of randomized controlled trials of low-carbohydrate vs. low-fat/low-calorie diets in the management of obesity and its comorbidities. Obes Rev 2009;10: 36-50.
13. Kien CL. Dietary interventions for metabolic syndrome: role of modifying dietary fats. Curr Diab Rep 2009;9:43-50.
14. Simmen FA, Badinga L, Green ML et al. The porcine insulin-like growth factor system: at the interface of nutrition, growth and reproduction. J Nutr 1998;128:315S-320S.
15. Spurlock ME, Gabler NK. The development of porcine models of obesity and the metabolic syndrome. J Nutr 2008;138:397-402.
16. Rocha D, Plastow G. Commercial pigs: an untapped resource for human obesity research? Drug Discov Today 2006;11:475-477.
17. Suster D, Leury BJ, Ostrowska E et al. Accuracy of dual energy X-ray absorptiometry (DXA), weight and P2 back fat to predict whole body and carcass composition in pigs within and across experiments. Livestock Prod Sci 2003;84:231-242.
18. Dunshea FR, Harris DM, Bauman DE, Boyd RD, Bell AW. Effect of somatotropin on nonesterified fatty acid and glycerol metabolism in growing pigs. J Anim Sci 1992;70:132-140.
19. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-994.
20. Foulstone EJ, Meadows KA, Holly JM, Stewart CE. Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF E-induced apoptosis. J Cell Physiol 2001;189:207-215.
21. Sabin MA, Stewart CE, Crowne EC et al. Fatty acid-induced defects in insulin signalling, in myotubes derived from children, are related to ceramide production from palmitate rather than the accumulation of intramyocellular lipid. J Cell Physiol 2007;211:244-252.
22. Sabin MA, Crowne EC, Stewart CE et al. Depot-specific effects of fatty acids on lipid accumulation in children's adipocytes. Biochem Biophys Res Commun 2007;361:356-361.
23. Sébert SP, Lecannu G, Kozlowski F et al. Childhood obesity and insulin resistance in a Yucatan mini-piglet model: putative roles of IGF-1 and muscle PPARs in adipose tissue activity and development. Int J Obes (Lond) 2005;29:324-333.
24. Hedbacker K, Birsoy K, Wysocki RW et al. Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab 2010;11:11-22.
25. Wheatcroft SB, Kearney MT, Shah AM et al. IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes 2007;56:285-294.
26. Chavez JA, Knotts TA, Wang LP et al. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 2003;278:10297-10303.
27. Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol 2006;48:677-685.
28. Buettner R, Parhofer KG, Woenckhaus M et al. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol 2006;36:485-501.
29. Del Moral ML, Esteban FJ, Torres MI et al. High-fat sunflower and olive oil diets affect serum lipid levels in steatotic rat liver differently. J Nutr Sci Vitaminol 1997;43:155-160.
30. Storlien LH, Jenkins AB, Chisholm DJ et al. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 1991;40:280-289.
31. Tsunoda N, Ikemoto S, Takahashi M et al. High-monounsaturated fat dietinduced obesity and diabetes in C57BL/6J mice. Metabolism 1998;47: 724-730.
32. Galgani JE, Uauy RD, Aguirre CA, Díaz EO. Effect of the dietary fat quality on insulin sensitivity. Br J Nutr 2008;100:471-479.
33. Owen RW, Giacosa A, Hull WE et al. Olive-oil consumption and health: the possible role of antioxidants. Lancet Oncol 2000;1:107-112.
34. Ostrowska E, Gabler NK, Ridley D, Suster D, Eagling DR and Dunshea FR. Extra-virgin and refined olive oils decrease plasma triglyceride, moderately affect lipoprotein oxidation susceptibility and increase bone density in growing pigs. J Sci Food Agric 2006;86:1955-63.
35. Sanders TA. Olive oil and the Mediterranean diet. Int J Vitam Nutr Res 2001;71:179-184.
36. Gong Z, Holly EA, Wang F, Chan JM, Bracci PM. Intake of fatty acids and antioxidants and pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area. Int J Cancer 2010;127:1893-1904.
37. Reinehr T, Panteliadou A, de Sousa G, Andler W. Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and growth in obese children before and after reduction of overweight. J Pediatr Endocrinol Metab 2009;22:225-233.
38. Claudio M, Benjamim F, Riccardo B et al. Adipocytes IGFBP-2 expression in prepubertal obese children. Obesity (Silver Spring) 2010;18:2055-2057.
39. Rehfeldt C, Renne U, Sawitzky M, Binder G, Hoeflich A. Increased fat mass, decreased myofiber size, and a shift to glycolytic muscle metabolism in adolescent male transgenic mice overexpressing IGFBP-2. Am J Physiol Endocrinol Metab 2010;299:E287-E298.
40. Sabin MA, De Hora M, Holly JM et al. Fasting nonesterified fatty acid profiles in childhood and their relationship with adiposity, insulin sensitivity, and lipid levels. Pediatrics 2007;120:e1426-e1433.